Centre for Sports Cardiology - Internal General Medicine Department, AUSL della Romagna - District of Cesena, Italy
Corresponding author details:
Masimo Bolognesi
Centre for Sports Cardiology - Internal General Medicine Department
AUSL della Romagna -District of Cesena
Italy
Copyright:
© 2020 Bolognesi M. This is an
open-access article distributed under the
terms of the Creative Commons Attribution
4.0 international License, which permits
unrestricted use, distribution, and
reproduction in any medium, provided the
original author and source are credited
The Pickelhaube Sign is today recognized as a novel Echocardiographic Risk Marker for
Malignant Mitral Valve Prolapse Syndrome. In this short manuscript the author describes
the case of an asymptomatic and fit amateur 46-year old male cyclist who has a mitral valve
prolapse with mild to moderate mitral regurgitation. He also showed sporadic uncommon
Premature Ventricular Contractions (PVCs) at exercise stress test, and the Pickelhaube
sign during sports preparticipation screening. So, his eligibility for sports competition was
questionable.
Mitral Valve Prolapse (MVP) has long been recognized to be a relatively common valve abnormality in the general population [1,2]. Patients with relatively non-specific symptoms and asymptomatic athletes who have MVP still represent an important clinical conundrum for any physician involved in preventive medicine and sports screening[3].Although cardiac arrhythmias and/or cardiac death are an undesirable problem in MVP patients, when these subjects were studied with HolterElectrocardiogram (ECG) monitoring a prevalence of ventricular arrhythmias up to 34% was observed, with premature ventricular contractions as the most common pattern (66% of cases) [4]. At this regard a paper by Anders et al. described a series of cases that suggest that even clinically considered benign cases of MVP in young adults may cause sudden and unexpected death[5]. However, cardiac arrest and Sudden Arrhythmic Cardiac Death (SCD) resulted in rare events only in patients with MVP based on data from a community study[6].
For a long time the mysterious entity of the mitral valve prolapse has been the subject
of an always fruitful discussion among sports cardiologists in association with scientist and
experts of sudden cardiac death. This association between arrhythmogenic mitral valve
prolapse and sudden cardiac death of athletes carrying this congenital valve abnormality
has recently led many anatomopathologists in collaboration with cardiologists to report
some papers about malignant MVP.With this anedoctal case report the author gives
information about a typical situation that can occur in the setting of sport medicine and
sports preparticipation screening in everyday practice.
A middle-aged athletic male who has been practicing competitive cycling for about
20 years came to our Sports Medicine Centre to undergo screening of sports preparation
for competitive cycling and the related renewal of certification for participation in sports
competitions. This athlete was always considered suitable in previous competitive
fitness assessments performed in other sports medicine centers. His family history was
unremarkable, as well as his recent and remote pathological anamnesis. The physical
examination revealed a regurgitation heart murmur, 3/6 intensity, at the cardiac apex with
a click in the mid late systole. Previous echocardiographic examinations revealed a mitral
valve prolapse which was considered benign with mild mitral regurgitation hemodinamicly
not relevant. He did not complain of symptoms such as dyspnea or heart palpitations during
physical activity. The resting ECG (Figure 1) showed negative T waves in the inferior limb
leads, and the stress test showed sporadic premature ventricular beats (a couple) with right
bundle branch block morphology (Figure 2). An echocardiogram confirmed the presence of
a classic mitral valve prolapse with billowing of both mitral leaflets (Figure 3), associated
with a mild to moderate valve regurgitation. The TDI exam at the level of the lateral mitral
annulus showed a high-velocity mid-systolic spike (Figure 4) like a Pickelhaube sign, i.e.
spiked German military helmet morphology. Consequently, an in-depth diagnostic imaging
with cardiac magnetic resonance imaging was proposed, but the athlete refused it, both
because he was totally asymptomatic and above all because he would be forced to pay a
considerable amount of money as the examination is not guaranteed by the Italian National
Health Service. In conclusion, the athlete remained sub judice as for competitive suitability,
Figure 1: Resting ECG shows negative T waves in the inferior
limb leads
Figure 2: Ex-ECG stress test shows a couple of PVCs with RBBB
morphology
Figure 3: 2DTT echocardiogram shows a classical billowing of
bileaflets MVP
The association between arrhythmogenic mitral valve prolapse
and sudden death of athletes is a growing topic between experts of
sports cardiology medicine. This congenital mitral valve abnormality
has recently led many anatomopathologists in collaboration with
cardiologists to report some papers about malignant MVP. However,
this makes us wonder why, despite being such a frequent anomaly in the population, the risk of sudden death is so rare and so difficult to
prove. Indeed, only autopsy examinations have shown the presence
of MVP in people and athletes who died suddenly without any
other apparent structural or organic heart disease, so this logical
deduction and clinical association was born. In order to reinforce
such assumption, even cardiovascular imaging diagnostics have
shown that these subjects with high-risk arrhythmogenic PVM often
show mitral postero lateral mitral fibrosis with evidence of LGE[7,8].
So, what more does it takes today to stop all athletes showing
these arrhythmogenic electrocardiographic, echocardiographic
and cardiovascular imaging features? Brilliant authors hypothesize
that the tugging of the posteromedial papillary muscle in midsystole by the myxomatous prolapsing leaflets causes the adjacent
posterobasal left ventricular wall to be pulled sharply toward the
apex, resulting in the showed spiked configuration of the lateral
annular velocities[7]. Furthermore, it has been suggested that this
mechanical traction of the papillary muscles and posterolateral left
ventricular wall is arrhythmogenic with early electrical dysfunction
being recognized during electrophysiological studies even in the
absence of gadolinium enhancement on CMR[8]. Endocardial friction
lesions in the inferolateral mural endocardium are considered able
to provoke ventricular arrhythmias in myxomatous mitral valve
disease and MVP[9]. In addition, recent CMR studies[10]have
shown delayed gadolinium enhancement in these areas suggesting
a myocardial damage like fibrosis. All these newest findings support
the assumption of the emerging risk markers of arrhythmogenic
MVP syndrome, suggesting the possibility, but not the probability,
that this spiked tissue Doppler velocity profile may be a risk marker
for malignant arrhythmias in patients with Myxomatous Mitral Valve
Disease and Bileaflet Mitral Valve Prolapse.
Figure 4: 2DTT echocardiogram shows TDI pattern with highvelocity mid-systolic spike named Pickelhaube Sign, like spiked
German military helmet
Finally, the question is: does MVP really cause sudden death?Is it
enough to detect the Pickelhaube signal by echocardiography to stop
this athlete? Let us bear in mind that this athlete was asymptomatic,
and he had not had any trouble during exercise and maximal effort for
many years. Why must we declare him unsuitable to do competitive
sports? What are the probabilities that he could have sudden cardiac
death? Just because there is a new theorem about sudden cardiac
death and MVP? In my humble opinion, there appears to be a slight
increase in the risk of sudden death from ventricular tachycardia or
ventricular fibrillation in people who have truly significant MVP, but
not in the large majority of people who have received the diagnosis
of MVP. Most athletes diagnosed with MVP have an extremely mild
form of the condition, which carries no measurable risk, even though
they have the Pickelhaube sign or slight myocardial fibrosis at the basal posterior and inferolateral LV wall.Initial evidence that MVP
may be associated with sudden death came mainly from autopsy
series. In studies in which the heart has been carefully examined in
people who have died suddenly, evidence of MVP can be found in a
substantial minority. So naturally, MVP has been assumed to be the
cause of these sudden deaths. However, two things are generally
not mentioned in these studies. Firstly, many sudden death victims
have no identifiable cardiac abnormality at all. Secondly, when there
is a determination to find MVP, at least some evidence of it will be
found in a large proportion of the general population. There is very
little evidence that the vast majority of people diagnosed with MVP
have any measurably increased risk of sudden death. Therefore, it
is very difficult to penalize and disqualify asymptomatic athletes
who are carriers of PVM and other signs such as Pickelhaube, only
on the basis of theorems and hypothetical assumptions elaborated
by genius minds such as the world’s experts on sudden cardiac
death, when in fact there are arrhythmogenic cardiac deaths and
channelopathies still unknown today that occur in athletes with
structurally normal hearts and/or other mild anomalies without
any meaning. The screening of sports preparticipation in Master
amateur or Veteran athletes hides many pitfalls and controversies.
The current knowledge in this field is really rare, considering that the
Italian law is based on scientific evidence carried out on a population
of young people less than 35 years of age. The high incidence of
false positives in middle-aged amateur athletes leads to requiring
additional and expensive cardiovascular imaging examinations, with
the real possibility that these third-level cardiological examinations
will fail to solve the clinical question if the athlete could have a
submerged and potentially dangerous disease. This is detrimental
for the individual athlete, sports and health service.
Copyright © 2020 Boffin Access Limited.